1 / 16

Good Morning All! 

Good Morning All! . Morning Report: Tuesday, March 6th. Pediatric Idiopathic Intracranial Hypertension. AKA: Pseudotumor Cerebri. Definition. Elevated ICP without any evidence of neurologic disease. Epidemiology. Adults. Children. Female predilection

donkor
Télécharger la présentation

Good Morning All! 

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Good Morning All! Morning Report: Tuesday, March 6th

  2. Pediatric Idiopathic Intracranial Hypertension AKA: PseudotumorCerebri

  3. Definition • Elevated ICP without any evidence of neurologic disease

  4. Epidemiology Adults Children • Female predilection • Rare in adults older than 45 (most common ages 20-44) • Strong association with obesity • Female predilection after puberty • Rare before age 10 (before puberty) • Association with obesity increases with age *No racial predisposition or genetic locus

  5. Pathogenesis • Elusive!! • Absence of an increase in ventricular size despite increased ICP also puzzling • Vision loss • Transmission of high ICP to optic nerve head axoplasmic stasis and microvascular compromise

  6. Differential Diagnosis • Diagnosis of EXCLUSION!! • No other identifiable neurologic disease • Numerous “associations” with IIH • Nomenclature dictates that identifiable causative factors be excluded from the diagnosis of IIH and be referred to as “secondary causes of intracranial HTN.”

  7. Clinical Evaluations • History • HA • Worse in AM • Awaken patient from sleep • Increase with Valsalva • Nausea/ vomiting • Ophthalmic symptoms • Decreased/ blurred vision • Diplopia • Transient visual obscurations • Other: ataxia, dizziness, neck/shoulder/back pain, stiff neck, facial or limb paresthesias, facial nerve palsy, pulsatile tinnitus

  8. Clinical Evaluations • Physical Exam • Ophthalmologic exam • Papilledema*

  9. Clinical Evaluations • Physical Exam • Ophthalmologic exam (con’t) • Afferent pupillary defect • Color vision defecit • Loss of visual acuity • Uni-or bilateral sixth nerve palsy • Third or fourth nerve paresis • Neurologic exam • Excluding ophthalmic findings, exam should be NORMAL!

  10. Investigations • MRI/MRV • Imaging studies of choice for IIH • Exclude the possibility of herniation prior to LP (older children and adults) • Identify secondary causes of increased ICP • Sinus or venous thrombosis • Malignancy • Meningeal abnormalities • Gliomatosiscerebri • Should be normal except for signs of increased ICP • Ventricles should be of normal to small size

  11. Investigations • CSF studies • Elevated opening pressure (>180-200 mm H20) • Normal cell count, protein and glucose • Absence of infection • Ancillary studies • Lots of ophtho specific testing that I have NEVER heard of….AND • Visual field testing • More sensitive than visual acuity and contrast sensitivity testing in the detection of worsening disease

  12. Management • Medical • Acetazolamide • Carbonic anhydrase inhibitor that reduces CSF production • 25-100 mg/kg/d, max 2g/d • Contraindicated in sulfa allergy and in significant renal or liver dz • Furosemide • Can be used in combination with or instead of acetazolamide • Effect on CSF production weaker than acetazolamide • Corticosteroids • Should be administered with caution • Used in conjunction with diuretics to treat children who’s response to diuretics was poor

  13. Management • Surgical • Optic nerve sheath decompression • CSF shunting • Weight management • +/- bariatric surgery

  14. Prognosis and Follow-up • *Vision loss can be permanent!* • Predictors of vision loss in IIH • Recent weight gain • Subretinal hemorrhage • Significant visual field loss at presentation • HTN • High-grade papilledema • Disc appearance cannot be used to predict final outcome • CLOSE follow-up • 1 month intervals for 6-12 mos after the disease has stabilized, then less frequently for a minimum of 5 years

  15. Thanks for your attention! Noon Conference: Mead Johnson Webinar, Pediatric Mental Health (LUNCH PROVIDED!!!)

More Related